Cargando…

Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study

BACKGROUND: Inactivated trivalent poliovirus vaccine (IPV) induces humoral immunity, which protects against paralytic poliomyelitis but does not induce sufficient mucosal immunity to block intestinal infection. We assessed the intestinal immunity in healthy adults in Belgium conferred by a co-formul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erdem, Rahsan, De Coster, Ilse, Withanage, Kanchanamala, Mercer, Laina D., Marchant, Arnaud, Taton, Martin, Cools, Nathalie, Lion, Eva, Cassels, Fred, Higgins, Deborah, Ivinson, Karen, Locke, Emily, Mahmood, Kutub, Wright, Peter F., Gast, Chris, White, Jessica A., Ackerman, Margaret E., Konopka-Anstadt, Jennifer L., Mainou, Bernardo A., Van Damme, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996288/ https://www.ncbi.nlm.nih.gov/pubmed/36746739 http://dx.doi.org/10.1016/j.vaccine.2023.01.048

Ejemplares similares

U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge
por: Coria, Lorena M., et al.
Publicado: (2020)

The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
por: Clements, John D., et al.
Publicado: (2018)

Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant
por: Toprani, Vishal M., et al.
Publicado: (2017)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
por: De Coster, Ilse, et al.
Publicado: (2021)

Identifying a stable bulk dmLT adjuvant formulation at a clinically relevant concentration
por: Estrada, Marcus R., et al.
Publicado: (2023)

Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial
por: Crothers, Jessica W., et al.
Publicado: (2022)

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study
por: Van Damme, Pierre, et al.
Publicado: (2019)

dmLT Adjuvant Enhances Cytokine Responses to T Cell Stimuli, Whole Cell Vaccine Antigens and Lipopolysaccharide in Both Adults and Infants
por: Akhtar, Marjahan, et al.
Publicado: (2021)

Route and antigen shape immunity to dmLT-adjuvanted vaccines to a greater extent than biochemical stress or formulation excipients
por: Stone, Addison E., et al.
Publicado: (2023)

The LT1 and LT2 variants of the enterotoxigenic Escherichia coli (ETEC) heat-labile toxin (LT) are associated with major ETEC lineages
por: Joffré, Enrique, et al.
Publicado: (2016)

Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge
por: Harro, Clayton, et al.
Publicado: (2019)

LTA1 and dmLT enterotoxin-based proteins activate antigen-presenting cells independent of PKA and despite distinct cell entry mechanisms
por: Valli, Eduardo, et al.
Publicado: (2020)

Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge
por: Stone, Addison E., et al.
Publicado: (2021)

Corrigendum to “Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial” [Vaccine 40(19) (2022) 2705–2713]
por: Crothers, Jessica W., et al.
Publicado: (2022)

Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials
por: Wahid, Rahnuma, et al.
Publicado: (2022)

Expression of proteins Heat-Labile (Lt-1) and Heat-Stable (STa) Escherichia coli expression of proteins Heat-Labile (Lt-1) and Heat-Stable (STa) Escherichia coli
por: Cavalcante, Alessandra, et al.
Publicado: (2014)

The adjuvants dmLT and mmCT enhance humoral immune responses to a pneumococcal conjugate vaccine after both parenteral or mucosal immunization of neonatal mice
por: Molina Estupiñan, Jenny Lorena, et al.
Publicado: (2023)

Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children
por: Wahid, Rahnuma, et al.
Publicado: (2022)

Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc
por: Zalem, Dani, et al.
Publicado: (2021)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3
por: Yeh, Ming Te, et al.
Publicado: (2023)

Adjuvant effect of enterotoxigenic Escherichia coli (ETEC) double-mutant heat-labile toxin (dmLT) on systemic immunogenicity induced by the CFA/I/II/IV MEFA ETEC vaccine: Dose-related enhancement of antibody responses to seven ETEC adhesins (CFA/I, CS1-CS6)
por: Seo, Hyesuk, et al.
Publicado: (2019)

Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results( )
por: Withanage, Kanchanamala, et al.
Publicado: (2021)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
por: Sáez-Llorens, Xavier, et al.
Publicado: (2021)

Both LTA and LTB Subunits Are Equally Important to Heat-Labile Enterotoxin (LT)-Enhanced Bacterial Adherence
por: Duan, Qiangde, et al.
Publicado: (2023)

The Divergent CD8(+) T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits
por: Hu, John C., et al.
Publicado: (2015)

Achieving High Poliovirus Antibody Seroprevalence in Areas at Risk of Vaccine-Derived Poliovirus Transmission—Niger Experience
por: Ousmane, Sani, et al.
Publicado: (2021)

Design of an improved multiplex PCR method for diagnosis of enterohaemoraghic E.coli and enteropathogic E.coli pathotypes
por: Soleimani, Mohammad, et al.
Publicado: (2012)

Intradermal Administration of the Type II Heat-Labile Enterotoxins LT-IIb and LT-IIc of Enterotoxigenic Escherichia coli Enhances Humoral and CD8(+) T Cell Immunity to a Co-Administered Antigen
por: Hu, John C., et al.
Publicado: (2014)

Alkaline pH Is a Signal for Optimal Production and Secretion of the Heat Labile Toxin, LT in Enterotoxigenic Escherichia Coli (ETEC)
por: Gonzales, Lucia, et al.
Publicado: (2013)

Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)
por: Norton, Elizabeth B., et al.
Publicado: (2015)

Whole-Genome Shotgun Sequences of Salmonella enterica Serovar Typhimurium Lilleengen Type Strains LT1, LT18, LT19, LT20, LT21, and LT22
por: Kazmierczak, Robert A., et al.
Publicado: (2017)

A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad
por: Gamougam, Kadidja, et al.
Publicado: (2021)

Correction: Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC)
Publicado: (2015)

VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen
por: Dawson, Erica D., et al.
Publicado: (2022)

Antibody against recombinant heat labile enterotoxin B subunit (rLTB) could block LT binding to ganglioside M1 receptor
por: Salimian, J, et al.
Publicado: (2010)

Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization
por: Konopka-Anstadt, Jennifer L., et al.
Publicado: (2020)

Escherichia coli O8:H8 Carrying a Novel Variant of the Heat-Labile Enterotoxin LT2 Gene Caused Outbreaks of Diarrhea
por: Ishimaru, Kai, et al.
Publicado: (2020)

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey
por: Kennedy, Stephen B, et al.
Publicado: (2023)

Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium
por: Brickley, Elizabeth B, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ads9k1o491goeffn9aetkbf0j